A Zambruni, F Trevisani, P Caraceni, M Bernardi - Journal of hepatology, 2006 - Elsevier
Abnormalities in cardiac electrophysiology are well documented in patients with liver cirrhosis. The mechanisms underlying their occurrence are not fully understood, although it …
Doxorubicin (DOX) is a chemotherapeutic agent used for treatment of different cancers and its clinical usage is hindered by the oxidative injury-related cardiotoxicity. This work aims to …
M Davis - Clinical pharmacokinetics, 2007 - Springer
A class of endogenous Opioids is upregulated in liver disease particular to cholestasis, which contributes to symptoms in liver disease such as pruritus, hypotension and …
D Saleh, M Abdelbaset, A Hassan, O Sharaf… - Plos one, 2020 - journals.plos.org
This study examines the protective effects of omega‐3 fatty acids (OMG), a frequently used nutritional therapy in cancer patients, against doxorubicin (DOX)‐induced acute cardiorenal …
Abstract Background/Aims: Acute cholestasis is associated with cardiovascular complications. The purpose of the present study was to investigate the effect of cholestasis …
L Moezi, AR Dehpour - Liver International, 2013 - Wiley Online Library
Cholestatic liver disease is associated with widespread derangements in the cardiovascular system, such as bradycardia, hypotension, QT prolongation and peripheral vasodilation; it is …
Doxorubicin (DOX) is the cornerstone of chemotherapy. However, it has dose-dependent cardiotoxic events that limit its clinical use. This study was intended to investigate the …
M Nasehi, M Piri, K Abbolhasani… - Behavioural …, 2013 - journals.lww.com
Bile duct ligation (BDL) is an animal model used in cholestatic disease research. Both opioidergic and nitrergic systems are known to be involved in cholestasis. The aim of this …
BACKGROUND/AIMS: Acute cholestasis is associated with cardiovascular complications, which mainly manifest during stressful conditions. The goal of this study is to evaluate …